Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate
Takeda』s investigational Zika virus vaccine candidate (TAK-426) progresses into Phase 1 clinical trial The clinical trial (ZIK-101) will evaluate safety and immunogenicity of TAK-426 in 24......